Clinical Trial Search Results for "A2Z-TIMI 21"

Blazing, M. A., De Lemos, J. A., Dyke, C. K., Califf, R. M., Bilheimer, D., Braunwald, E. The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy Am Heart J. 2001;142(2):211-7.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Brady, W. E., White, H. D., Fox, K. A., Palmisano, J., Ramsey, K. E., Bilheimer, D. W., Lewis, E. F., Pfeffer, M., Califf, R. M., Braunwald, E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial Eur Heart J. 2004;25(19):1688-94.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A., White, H. D., Rouleau, J. L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., Ramsey, K. E., Palmisano, J., Bilheimer, D. W., Pfeffer, M. A., Califf, R. M., Braunwald, E. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA. 2004;292(11):1307-16.

Morrow, D. A., de Lemos, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., White, H. D., Fox, K. A., Califf, R. M., Braunwald, E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA. 2005;294(22):2866-71.

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., Braunwald, E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation. 2006;114(4):281-8.

Wiviott, S. D., Cannon, C. P. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy Curr Opin Lipidol. 2006;17(6):626-30. Abstract

de Lemos, J. A., Wiviott, S. D., Murphy, S. A., Blazing, M. A., Lewis, E. F., Califf, R. M., Pfeffer, M. A., Braunwald, E. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial Am J Cardiol. 2006;98(6):739-42.

de Lemos, J. A., Morrow, D. A., Blazing, M. A., Jarolim, P., Wiviott, S. D., Sabatine, M. S., Califf, R. M., Braunwald, E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial J Am Coll Cardiol. 2007;50(22):2117-24. Abstract

Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., Mahaffey, K. W., Scirica, B. M., Skene, A., Steg, P. G., Storey, R. F., Harrington, R. A., Plato Investigators, Freij, A., Thorsen, M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med. 2009;361(11):1045-57. Abstract